1-3 of 3
Cooperative Study Group A for Hematology
Close
Sort by
Journal Articles

A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia

Clinical Trials & Observations
Je-Hwan Lee, Young-Don Joo, Hawk Kim, Sung Hwa Bae, Min Kyoung Kim, Dae Young Zang, Jung-Lim Lee, Gyeong Won Lee, Jung-Hee Lee, Jae-Hoo Park, Dae-Young Kim, Won-Sik Lee, Hun Mo Ryoo, Myung Soo Hyun, Hyo Jung Kim, Young Joo Min, Yae-Eun Jang, Kyoo-Hyung Lee, for the Cooperative Study Group A for Hematology
Journal: Blood
Blood (2011) 118 (14): 3832–3841.
https://doi.org/10.1182/blood-2011-06-361410
Published: 2011
Journal Articles

Continuous Infusion of FLAG and Idarubicin for Patients Younger Than 60 Years with Resistant Acute Myeloid Leukemia; a Prospective, Multicenter Phase II Study.

Hawk Kim, MD, PhD, Jae-Hoo Park, MD, PhD, Je-Hwan Lee, MD, PhD, Jung-Hee Lee, MD, PhD, Young-Don Joo, MD, PhD, Won-Sik Lee, MD, PhD, Sung-Hwa Bae, MD, PhD, Hun Mo Ryoo, MD, PhD, Kyoo-Hyung Lee, MD, PhD, Cooperative Study Group A for Hematology
Journal: Blood
Blood (2007) 110 (11): 4350.
https://doi.org/10.1182/blood.V110.11.4350.4350
Published: 2007
Journal Articles

Standard Induction Followed by Attenuated Consolidation Therapy in Elderly Patients with Acute Myeloid Leukemia.

Je-Hwan Lee, MD, Seong-Jun Choi, MD, Jung-Hee Lee, MD, Miee Seol, RN, Keun Hee Kim, RN, Jae-Hoo Park, MD, Hawk Kim, MD, Young-Don Joo, MD, Won Sik Lee, MD, Dae Young Zang, MD, Hyo Jung Kim, MD, Kyoo-Hyung Lee, MD, Cooperative Study Group A for Hematology
Journal: Blood
Blood (2005) 106 (11): 4602.
https://doi.org/10.1182/blood.V106.11.4602.4602
Published: 2005